Smart partnership for cancer diagnosis

Cancer is tough on individuals and families. While there is physical and mental side to battle out another dimensions which adds to the burden is the cost of diagnosis and treatment.
But what if there was a way to detect cancer early, when it is most treatable, and reduce the financial and emotional burden of cancer care? That's the goal of a groundbreaking partnership between John Hancock, Munich Re, and Grail.

Role of life . . .

To view the content of this page you need to login or upgrade your account